NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry
Ekso Bionics Holdings (NASDAQ: EKSO) has named National Seating & Mobility (NSM) as the exclusive distributor of Ekso Indego® Personal device within the Complex Rehabilitation Technology (CRT) industry in the United States. The Ekso Indego Personal is a powered exoskeleton that enables individuals with spinal cord injuries to stand and walk independently.
The device features a unique modular quick connect design allowing users to operate it without assistance, and is the lightest commercial exoskeleton available. Users have demonstrated faster walking speeds with its advanced gait mode, enhancing their community independence.
NSM, a leading provider of CRT and mobility solutions, will leverage its expertise and insurance partnerships to expand access to the technology. The partnership aligns with Ekso Bionics' growth strategy and aims to broaden the availability of innovative mobility solutions.
Ekso Bionics Holdings (NASDAQ: EKSO) ha nominato National Seating & Mobility (NSM) come distributore esclusivo del dispositivo Ekso Indego® Personal nel settore della Tecnologia di Riabilitazione Complessa (CRT) negli Stati Uniti. L'Ekso Indego Personal è un esoscheletro motorizzato che consente a persone con lesioni del midollo spinale di stare in piedi e camminare in modo autonomo.
Il dispositivo presenta un design modulare unico con un sistema di connessione rapida che permette agli utenti di utilizzarlo senza assistenza ed è il più leggero esoscheletro commerciale disponibile. Gli utenti hanno dimostrato una maggiore velocità di camminata grazie alla sua modalità avanzata di deambulazione, migliorando così la loro indipendenza nella comunità.
NSM, un fornitore leader di soluzioni CRT e di mobilità, sfrutterà la propria esperienza e le partnership con le assicurazioni per ampliare l'accesso a questa tecnologia. La partnership si allinea con la strategia di crescita di Ekso Bionics e mira a ampliare la disponibilità di soluzioni innovative per la mobilità.
Ekso Bionics Holdings (NASDAQ: EKSO) ha nombrado a National Seating & Mobility (NSM) como el distribuidor exclusivo del dispositivo Ekso Indego® Personal dentro de la industria de Tecnología de Rehabilitación Compleja (CRT) en los Estados Unidos. El Ekso Indego Personal es un exoesqueleto motorizado que permite a individuos con lesiones medulares estar de pie y caminar de manera independiente.
El dispositivo cuenta con un diseño modular único de conexión rápida que permite a los usuarios operarlo sin ayuda, y es el exoesqueleto comercial más ligero disponible. Los usuarios han demostrado velocidades de caminata más rápidas con su modo de marcha avanzada, mejorando su independencia en la comunidad.
NSM, un proveedor líder de soluciones CRT y movilidad, aprovechará su experiencia y asociaciones con seguros para expandir el acceso a la tecnología. La asociación se alinea con la estrategia de crecimiento de Ekso Bionics y tiene como objetivo ampliar la disponibilidad de soluciones innovadoras de movilidad.
Ekso Bionics Holdings (NASDAQ: EKSO)는 National Seating & Mobility (NSM)를 미국의 복합 재활 기술 (CRT) 산업 내 Ekso Indego® Personal 장치의 독점 유통업체로 지정했습니다. Ekso Indego Personal은 척수 손상으로 인한 개인이 독립적으로 서고 걸을 수 있도록 해주는 전동 외골격입니다.
이 장치는 사용자들이 도움 없이 조작할 수 있도록 하는 독특한 모듈식 빠른 연결 설계를 특징으로 하며, 가장 가벼운 상업용 외골격입니다. 사용자들은 고급 보행 모드를 통해 더 빠른 보행 속도를 증명하며, 지역 사회에서의 독립성을 향상시켰습니다.
NSM은 CRT 및 이동 솔루션의 선도적인 공급업체로, 자신의 전문성과 보험 파트너십을 활용하여 이 기술에 대한 접근성을 확대할 것입니다. 이 파트너십은 Ekso Bionics의 성장 전략과 일치하며 혁신적인 이동 솔루션의 가용성을 넓히는 것을 목표로 합니다.
Ekso Bionics Holdings (NASDAQ: EKSO) a désigné National Seating & Mobility (NSM) comme distributeur exclusif de l'appareil Ekso Indego® Personal dans le secteur de la Technologie de Réhabilitation Complexe (CRT) aux États-Unis. L'Ekso Indego Personal est un exosquelette motorisé qui permet aux personnes ayant subi des lésions de la moelle épinière de se tenir debout et de marcher de manière autonome.
Ce dispositif est doté d'un design modulaire unique avec un système de connexion rapide permettant aux utilisateurs de l'utiliser sans assistance, et c'est l'exosquelette commercial le plus léger disponible. Les utilisateurs ont démontré des vitesses de marche plus rapides grâce à son mode de marche avancé, améliorant ainsi leur indépendance au sein de la communauté.
NSM, un fournisseur leader de solutions CRT et de mobilité, tirera parti de son expertise et de ses partenariats avec les assureurs pour élargir l'accès à cette technologie. Ce partenariat s'aligne avec la stratégie de croissance d'Ekso Bionics et vise à élargir la disponibilité de solutions de mobilité innovantes.
Ekso Bionics Holdings (NASDAQ: EKSO) hat National Seating & Mobility (NSM) zum exklusiven Vertriebspartner für das Gerät Ekso Indego® Personal in der Branche der Komplexen Rehabilitationstechnologie (CRT) in den Vereinigten Staaten ernannt. Das Ekso Indego Personal ist ein motorisiertes Exoskelett, das es Personen mit Rückenmarksverletzungen ermöglicht, selbstständig zu stehen und zu gehen.
Das Gerät verfügt über ein einzigartiges modulares Schnellverbindungsdesign, das es den Benutzern ermöglicht, es ohne Unterstützung zu bedienen, und ist das leichteste kommerzielle Exoskelett, das es gibt. Benutzer haben mit dem fortschrittlichen Gangmodus schnellere Gehgeschwindigkeiten demonstriert, was ihre Unabhängigkeit in der Gemeinschaft verbessert.
NSM, ein führender Anbieter von CRT- und Mobilitätslösungen, wird seine Expertise und Versicherungskooperationen nutzen, um den Zugang zu dieser Technologie zu erweitern. Die Partnerschaft unterstützt die Wachstumsstrategie von Ekso Bionics und zielt darauf ab, die Verfügbarkeit innovativer Mobilitätslösungen zu erweitern.
- Secured exclusive distribution agreement with leading CRT provider NSM
- Partnership provides access to NSM's established insurance submission network
- Expands market reach for Ekso Indego Personal device across the United States
- None.
Insights
This exclusive distribution agreement marks a pivotal strategic move for Ekso Bionics, potentially transforming its market reach in the $3.9 billion U.S. complex rehabilitation technology market. NSM's position as a leading CRT provider, with extensive insurance partnerships and nationwide presence, could significantly accelerate the commercialization of Ekso Indego Personal.
The partnership addresses three critical market barriers: distribution infrastructure, insurance reimbursement expertise and clinical adoption. NSM's established relationships with insurance providers and experience in securing coverage approvals could substantially reduce the typically lengthy reimbursement process for powered exoskeletons, which often ranges from 6-12 months.
The Ekso Indego Personal's distinctive features create compelling competitive advantages:
- Modular quick-connect design enabling independent use
- Lightest commercial exoskeleton available, enhancing portability
- Advanced gait mode supporting faster walking speeds
From a market penetration perspective, this exclusive arrangement could accelerate adoption rates by leveraging NSM's extensive network of 200+ locations and established relationships with rehabilitation facilities. The partnership's focus on insurance coverage strategy is particularly significant, as reimbursement approval typically represents the primary barrier to adoption in the medical device market.
This strategic alignment positions Ekso Bionics to potentially capture a larger share of the growing powered exoskeleton market, which is projected to reach $2.8 billion by 2027. The exclusive nature of the agreement provides NSM with a unique offering in the CRT space while giving Ekso Bionics dedicated focus from a major distributor, creating mutual incentives for market expansion.
Move expected to broaden access to Ekso Bionics’ portable exoskeleton device for individuals living with spinal cord injuries and other mobility challenges across the United States
SAN RAFAEL, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has named National Seating & Mobility (“NSM”), a leading provider of complex rehabilitation technology (“CRT”), mobility and accessibility solutions, as the Company’s exclusive Ekso Indego® Personal device distributor within the CRT industry in the United States.
Ekso Indego Personal is a wearable lower extremity powered exoskeleton that enables certain individuals living with spinal cord injuries (“SCIs”) with the ability to stand and walk independently. It is the only known portable exoskeleton device to offer a modular quick connect design, which was engineered to allow users to put on and take off the device without assistance. Ekso Indego Personal is the lightest known commercial exoskeleton available offering ease of handling, transportation, and storage. Also offering an advanced gait mode, individuals with a SCI using the device have been shown to reach faster walking speeds, granting them a new level of independence in the community.
“We are excited to expand the distribution of the Ekso Indego Personal device through this strategic commercial partnership with NSM,” commented Scott Davis, the Company’s Chief Executive Officer. “Both companies see a world where people have widespread access to innovative technologies that allow them to rethink their current physical limitation. We are looking forward to working with NSM to make that a reality. And as a fast-growing, well-established company in the CRT space, NSM’s proven expertise and robust infrastructure are well aligned with our growth strategy.”
“NSM is committed to investing in resources and partnerships that enable us to bring the most advanced mobility and accessibility solutions to those we serve,” said Crispin Teufel, CEO of NSM. “We are proud to partner with Ekso Bionics to expand access to the life-changing Ekso Indego device to those who rely on CRT equipment and can benefit from the mobility and therapy this innovative technology provides.”
“We will apply both our expertise in providing one-of-a-kind mobility technologies for individuals with various conditions, and our experience with insurance submissions through our vast panel of insurance partners, to help bring Ekso Indego Personal to more people who could benefit from standing and walking in addition to wheeled mobility,” added Mr. Teufel.
About Ekso Bionics®
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on X.
About National Seating & Mobility
With a network of 180+ locations across the U.S. and Canada, National Seating & Mobility (NSM) is North America’s largest and most trusted provider of comprehensive mobility solutions including complex rehab technology (CRT), home and vehicle accessibility, and full-service maintenance and repair. NSM has been advancing independence and enhancing the quality of life of individuals who use mobility solutions for more than 30 years. The company has more than 2,400 dedicated team members who support more than 250,000 mobility solutions each year. Since 2006, NSM is the only national mobility solutions provider that is accredited by The Joint Commission and voluntarily undergoes a rigorous review process every few years to ensure and validate the company’s commitment to providing safe, quality care for our valued customers. For more information visit www.nsm-seating.com.
Forward-Looking Statements
Any statement contained in this press release that does not describe historical facts may constitute a forward-looking statement. Forward-looking statements may include, without limitation, statements regarding the ability of National Seating & Mobility to distribute the Company’s Ekso Indego Personal device within the complex rehabilitation technology industry in the United States, and the Company’s ability to bolster demand for its technology and execute on its long-term growth strategy. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon the Company’s current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company's inability to obtain adequate financing to fund and grow the Company's operations and to develop or enhance the Company’s technology, the Company’s inability to obtain future reimbursements from CMS in a timely manner and at the expected reimbursement levels, the Company’s inability to obtain insurance coverage beyond CMS, the Company’s inability to obtain additional indications of use for its devices, any delay or discontinuation of the sales and distribution of Esko Indego Personal within the complex rehabilitation technology industry, or Ekso Indego Personal risks related to product liability, recall and warranty claims. These and other factors are identified and described in more detail in the Company’s filings with the U.S. Securities and Exchange Commission. To learn more about Ekso Bionics please visit the Company’s website at www.eksobionics.com or follow @EksoBionics on X. The Company does not undertake to update these forward-looking statements, except as required by law.
Contact:
Stephen Kilmer
Investor Relations
Direct: (646) 274-3580
Email: skilmer@eksobionics.com
FAQ
What are the key features of EKSO's Indego Personal exoskeleton device?
How will the NSM distribution partnership affect EKSO's market reach?
What advantages does the EKSO Indego Personal offer compared to other exoskeletons?
How will NSM's insurance partnerships benefit EKSO's distribution?
